Early markers of inflammation in a high angiotensin II state - Results of studies in Bartter's/Gitelman's syndromes

Nephrology Dialysis Transplantation

Volumn 21, Issue 6, 2006, Pages 1697-1701

  Davis, Paul A ^a   Mussap, Michele ^b   Pagnin, Elisa ^b   Bertipaglia, Lara ^b   Savica, Vincenzo ^c   Semplicini, Andrea ^b   Calò, Lorenzo A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Angiotensin II; Atherosclerosis; Bartter's; Gitelman's syndrome; Hypertension; inflammation; Syndrome

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; NITRIC OXIDE; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; BARTTER SYNDROME; CARDIOVASCULAR DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GITELMAN SYNDROME; HUMAN; HYPERTENSION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; ANGIOTENSIN II; BARTTER SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745970439     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl112     Document Type: Article

References (19)

1. Undurti N Das. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 2005; 11: 155-162
2. Alexander RW. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response, a new perspective. Hypertension 1995; 25: 155-161
3. Tham DM, Martin-McNulty B, Wang YX et al. Angiotensin II is associated with activation of NF-κB mediated genes and downregulation of PPARs. Physiol Genom 2002; 11: 21-31
4. Ruiz-Ortega M, Ruperez M, Lorenzo O et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int 2002; 62 [Suppl 82]: 12-22
5. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injAry: Part II: animal and human studies. Circulation 2003; 108: 2034-2040
6. Touyz RM. Role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5: 155-164
7. Lassegue B, Griendling KK. Reactive oxygen species in hypertension. Am J Hypertens 2004; 17: 852-860
8. Nathan C. Points of control in inflammation. Nature 2002; 446-452
9. Himmelfarb J. Linking oxidative stress and inflammation in kidney disease: Which is the chicken and which is the egg? Semin Dial 2004; 17: 449-454
10. Calò LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005; 12: 17-26
11. Calò LA. Vascular tone control in humans: The utility of studies in Bartter's/Gitelman's syndromes. Kidney Int 2006; 69: 963-966
12. Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter's and Gitelman's syndromes. From gene to clinic. Nephron Physiol 2004; 96: 65-78
13. Calò L, Davis PA, Semplicini A. Bartter's/Gitelman's syndrome: A model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling. Clin Nephrol 2003; 59: 393-394
14. Schmeisser A, Soehnlein O, Illmer T et al. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-κB activity and AT1 receptor expression. Biochem Biophys Res Commun 2004; 325: 532-540
15. Calò L, Davis PA, Milani M et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol 1999; 51: 12-17
16. - and cyclic GMP levels in patients with Bartter's syndrome: Relationship to vascular reactivity. Am J Kidney Dis 1996; 27: 874-879
17. Calo L, Cantaro S, Calabro A et al. Endothelium-derived vasoactive substances in Bartter's syndrome. Angiology 1995; 46: 905-913
18. Cauwels A, Bultinck J, Brouckaert P. Dual role of endogenous nitric oxide in tumor necrosis factor shock: Induced NO tempers oxidative stress. Cell Mol Life Sci 2005; 62: 1632-1640
19. Min JK, Kim YM, Kim SW et al. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: Induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NFκB activation in endothelial cells. J Immunol 2005; 175: 531-540